First published on 26 October 2012. Updated 5 May 2023.
This is a monster of a guideline from NICE, which is only aimed at people over the age of 12. This contains the summary, but if you want to read more, then use the link at the bottom.
SIGN has done an updated guideline on migraine, and I have also done a blog on this.
My main feeling about this guideline, having trawled though the 360 pages of evidence, is that it is more a summary of what we currently know, than a guideline. They exclude commonly used treatments like pizotifen from the guideline, not because there is evidence that they are ineffective, but because the studies just haven’t been done yet. A lot of the evidence that is available, is of poor quality and is often contradictory.